Cited by 347Neurotransmitter Receptor Influence on BehaviorTreatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Do animal models of anxiety predict anxiolytic-like effects of antidepressants?

Borsini, Franco, Podhorna, Jana, Marazziti, Donatella·2002·Psychopharmacology

DOI 10.1007/s00213-002-1155-6

Open this paper in CoChat — free account

Abstract

Chronically administered antidepressant drugs, particularly selective serotonin (5-HT) reuptake inhibitors (SSRIs), are clinically effective in the treatment of all anxiety disorders, while the clinical effectiveness of "traditional" anxiolytics, such as benzodiazepines (BDZs), is limited to generalised anxiety disorder or acute panic attacks. This implies that animal models of anxiety should be sensitive to SSRIs and other antidepressants in order to have predictive validity. We reviewed the literature on the effects of antidepressants in the so-called animal models of anxiety and found that only the isolation-induced calls in guinea-pig pups may reveal anxiolytic-like action of all antidepressant classes after acute administration. Some other models, such as marble-burying or conditioned-freezing behaviours, and isolation- or shock-induced ultrasonic vocalisation models, may detect anxiolytic-like activity of acutely administered antidepressants, although the sensitivity of these models is usually limited to SSRIs and other drugs affecting 5-HT uptake. The predictive validity of models of "anxiety", such as the plus-maze and light-dark transition tests or stress-induced hyperthermia, appears to be limited to BDZ-related drugs. Far less work has been done on chronic administration of antidepressants in animal anxiety models. Unless and until such studies have been undertaken, the true predictive value of the anxiety models will remain unknown.

Integrity signals

Registry

Crossref · 10.1007/s00213-002-1155-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chronic antidepressant and clonidine treatment effects on conflict behavior in the rat
Commissaris, R. L., Ellis, D. M., Hill, T. J., Schefke, D. M., Becker, C. A., & Fontana, D. J. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90058-p · Cited by 21

Show all 1 references

Sorted by citations

Items 101–200 of 347

Neurobiological correlates of social anxiety disorder: an update
Marazziti, D., Abelli, M., Baroni, S., Carpita, B., Ramacciotti, C., & Dell’Osso, L. (2014) · CNS Spectrums · doi:10.1017/s109285291400008x · Cited by 59
Self-citation
SB-649915-B, a Novel 5-HT1A/B Autoreceptor Antagonist and Serotonin Reuptake Inhibitor, is Anxiolytic and Displays Fast Onset Activity in the Rat High Light Social Interaction Test
Starr, K. R., Price, G. W., Watson, J. M., Atkinson, P. J., Arban, R., Melotto, S., Dawson, L. A., Hagan, J. J., Upton, N., & Duxon, M. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301341 · Cited by 53
Brain angiotensin and anxiety-related behavior: The transgenic rat TGR(ASrAOGEN)680
Voigt, J., Hörtnagl, H., Rex, A., van Hove, L., Bäder, M., & Fink, H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.048 · Cited by 53
Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice
Ihne, J. L., Fitzgerald, P. J., Hefner, K. R., & Holmes, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.045 · Cited by 54
SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity
Depoortère, R., Boulay, D., Perrault, G., Bergis, O. E., Decobert, M., Françon, D., Jung, M., Simiand, J., Soubrié, P., & Scatton, B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300261 · Cited by 52
Attenuating effects of testosterone on depressive-like behavior in the forced swim test in healthy male rats
Buddenberg, T., Komorowski, M., Ruocco, L. A., Silva, M. A. D. S., & Topic, B. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.02.008 · Cited by 52
R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxiety
Sánchez, C. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00165-5 · Cited by 52
Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice
Thoeringer, C. K., Erhardt, A., Sillaber, I., Mueller, M., Ohl, F., Holsboer, F., & Keck, M. E. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109103091 · Cited by 51
Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model
Wu, C., Jiang, X.-L., Shen, H.-W., & Yu, A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.011 · Cited by 50
Anxiety in mice and men: a comparison
Hohoff, C. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0215-z · Cited by 50
Behavioral, biochemical and histological studies in a model of pilocarpine-induced spontaneous recurrent seizures
Szyndler, J., Wierzba‐Bobrowicz, T., Skórzewska, A., Maciejak, P., Walkowiak, J., Lechowicz, W., Turzyńska, D., Bidziński, A., & Płaźnik, A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.020 · Cited by 50
SSRIs and conditioned fear
Inoue, T., Kitaichi, Y., & Koyama, T. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.09.002 · Cited by 49
Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: Modulation of hypothalamic–pituitary–adrenal axis activity and brain-derived neurotrophic factor level
Jindal, A., Mahesh, R., & Bhatt, S. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.08.005 · Cited by 51
Anti-inflammatory agents attenuate the passive responses of guinea pig pups: Evidence for stress-induced sickness behavior during maternal separation
Hennessy, M. B., Schiml‐Webb, P. A., Miller, E. E., Maken, D. S., Bullinger, K. L., & Terrence Deak, B. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.03.004 · Cited by 49
Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter
Troelsen, K. B., Nielsen, E. Ø., & Mirza, N. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0032-5 · Cited by 49
Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test
Bechtholt, A. J., Hill, T. E., & Lucki, I. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0615-9 · Cited by 48
Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action
Andreasen, J. T., Fitzpatrick, C. M., Larsen, M., Skovgaard, L., Nielsen, S. D., Clausen, R. P., Troelsen, K. B., & Pickering, D. S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.001 · Cited by 48
Acute and chronic anxiogenic-like response to fluoxetine in rats in the elevated plus-maze: Modulation by stressful handling
Robert, G., Drapier, D., Bentué‐Ferrer, D., Renault, A., & Reymann, J. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.051 · Cited by 49
Assessing the effects of the antidepressant venlafaxine to fathead minnows exposed to environmentally relevant concentrations over a full life cycle
Parrott, J. L., & Metcalfe, C. D. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.06.009 · Cited by 51
Ethopharmacological analysis of the open elevated plus-maze in mice
Sorregotti, T., Mendes-Gomes, J., Rico, J. L., Rodgers, R. J., & Nunes‐de‐Souza, R. L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.035 · Cited by 46
The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes
Pereira, M. M., Morais, H., Silva, E. D. S., Corso, C. R., Adami, E. R., Carlos, R. M., Acco, A., & Zanoveli, J. M. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0264-9 · Cited by 45
MCL0042: A nonpeptidic MC4 receptor antagonist and serotonin reuptake inhibitor with anxiolytic- and antidepressant-like activity
Chaki, S., Oshida, Y., Ogawa, S., Funakoshi, T., Shimazaki, T., Okubo, T., Nakazato, A., & Okuyama, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.11.001 · Cited by 44
Anxiety and otovestibular disorders: Linking behavioral phenotypes in men and mice
Kalueff, A. V., Ishikawa, K., & Griffith, A. J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.032 · Cited by 44
Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: Effects of GYKI 52466 and its novel analogues
Kapus, G. L., Gacsályi, I., Végh, M., Kompagne, H., Hegedűs, E., Leveleki, C., Hársing, L. G., Barkóczy, J., Bilkei‐Gorzó, A., & Lévay, G. I. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1121-z · Cited by 44
Serotoninergic activation of the basolateral amygdala and modulation of tonic immobility in guinea pig
Leite‐Panissi, C. R. A., Tiballi, A. A. F., Terzian, A. L. B., & Menescal-de-Oliveira, L. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.02.007 · Cited by 45
Effects of chronic fluoxetine treatment on anxiety- and depressive-like behaviors in adolescent rodents – systematic review and meta-analysis
Kryst, J., Majcher‐Maślanka, I., & Chocyk, A. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00420-w · Cited by 49
Extinction-induced “despair” in the water maze, exploratory behavior and fear: Effects of chronic antidepressant treatment
Schulz, D., Buddenberg, T., & Huston, J. P. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.12.001 · Cited by 43
Stress-induced changes in group behaviour
Kleinhappel, T. K., Pike, T. W., & Burman, O. H. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-53661-w · Cited by 42
Characterization of 5-HT1A/1B−/− mice: An animal model sensitive to anxiolytic treatments
Guilloux, J., David, D. J. P., Xia, L., Nguyen, H. T., Rainer, Q., Guiard, B. P., Repérant, C., Deltheil, T., Tóth, M., Hen, R., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.009 · Cited by 51
Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity
Dawson, L. A., Hughes, Z. A., Starr, K. R., Storey, J. D., Bettelini, L., Bacchi, F., Arban, R., Poffe, A., Melotto, S., Hagan, J. J., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.010 · Cited by 42
Anxiety as a disorder of uncertainty: implications for understanding maladaptive anxiety, anxious avoidance, and exposure therapy
Brown, V. M., Price, R. B., & Dombrovski, A. Y. (2023) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-023-01080-w · Cited by 51
Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects
Gould, R. W., Amato, R. J., Bubser, M., Joffe, M. E., Nedelcovych, M. T., Thompson, A. D., Nickols, H. H., Yuh, J. P., Zhan, X., Felts, A. S., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.265 · Cited by 41
Modeling PTSD in the zebrafish: Are we there yet?
Caramillo, E. M., Khan, K. M., Collier, A. D., & Echevarria, D. J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.005 · Cited by 41
Evaluation of the acute effects of amitriptyline and fluoxetine on anxiety using grooming analysis algorithm in rats
Enginar, N., Hatipoğlu, İ., & Fırtına, M. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.02.001 · Cited by 41
Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender
Müller, W. E., Sillani, G., Schuwald, A. M., & Friedland, K. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104899 · Cited by 43
Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test
Dhonnchadha, B. �. N., Ripoll, N., Cl�net, F., Hascoët, M., & Bourin, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2044-y · Cited by 42
Overlapping and Distinct Brain Regions Associated with the Anxiolytic Effects of Chlordiazepoxide and Chronic Fluoxetine
Bechtholt, A. J., Valentino, R. J., & Lucki, I. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301616 · Cited by 40
GPR88 in A2AR Neurons Enhances Anxiety-Like Behaviors
Meirsman, A. C., Robé, A., d’Exaerde, A. D. K., & Kieffer, B. L. (2016) · eNeuro · doi:10.1523/eneuro.0202-16.2016 · Cited by 42
An effective dietary method for chronic tryptophan depletion in two mouse strains illuminates a role for 5-HT in nesting behaviour
Browne, C. A., Clarke, G. A., Dinan, T. G., & Cryan, J. F. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.009 · Cited by 42
Citalopram-mediated anxiolysis and differing neurobiological responses in both sexes of a genetic model of depression
Kokras, N., Sotiropoulos, I., Pitychoutis, P. M., Almeida, O. F. X., & Papadopoulou‐Daifoti, Z. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.077 · Cited by 39
Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders
Chaki, S., Okubo, T., & Sekiguchi, Y. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906775245318 · Cited by 39
Genetic Approaches to Modeling Anxiety in Animals
Jacobson, L. H., & Cryan, J. F. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_31 · Cited by 40
Parsing the Role of the Hippocampus in Approach–Avoidance Conflict
Loh, E., Kurth-Nelson, Z. L., Berron, D., Dayan, P., Düzel, E., Dolan, R. J., & Guitart‐Masip, M. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw378 · Cited by 38
Perinatal selective serotonin reuptake inhibitor (SSRI) and other antidepressant exposure effects on anxiety and depressive behaviors in offspring: A review of findings in humans and rodent models
Hutchison, S. M., Mâsse, L. C., Pawluski, J. L., & Oberlander, T. F. (2020) · Reproductive Toxicology · doi:10.1016/j.reprotox.2020.11.013 · Cited by 40
Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety
Nordquist, R. E., Steckler, T., Wettstein, J. G., Mackie, C. E., & Spooren, W. P. J. M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1096-9 · Cited by 39
The effects of the estrus cycle and citalopram on anxiety-like behaviors and c-fos expression in rats
Sayin, A., Derinöz, O., Yüksel, N., Şahin, S., & Bolay, H. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.06.002 · Cited by 39
Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents
Popik, P., Hołuj, M., Kos, T., Nowak, G., Librowski, T., & Sałat, K. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9759-0 · Cited by 36
Drug-, dose- and sex-dependent effects of chronic fluoxetine, reboxetine and venlafaxine on open-field behavior and spatial memory in rats
Gray, V., & Hughes, R. N. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.023 · Cited by 40
Individual differences in the effects of serotonergic anxiolytic drugs on the motivation to self-administer cocaine
Homberg, J. R., Arends, B., Wardeh, G., Raasø, H. S., Schoffelmeer, A. N. M., & Vries, T. J. D. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.048 · Cited by 36
Facilitation of Serotonin Signaling by SSRIs is Attenuated by Social Isolation
Dankoski, E. C., Agster, K. L., Fox, M. E., Moy, S. S., & Wightman, R. M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.162 · Cited by 36
Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic
Yokoyama, F., Yamauchi, M., Oyama, M., Okuma, K., Onozawa, K., Nagayama, T., Shinei, R., Ishikawa, M., Sato, Y., & Kakui, N. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1528-1 · Cited by 36
Antidepressant Treatment in Anxiety Disorders
Bespalov, A., van Gaalen, M. M., & Groß, G. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_3 · Cited by 34
Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations
Blažević, S. A., Čolić, L., Čulig, L., & Hranilović, D. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.02.001 · Cited by 35
Are benzodiazepines really anxiolytic?
Ennaceur, A., Michalíková, S., van Rensburg, R., & Chazot, P. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.10.026 · Cited by 33
Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent
Stachowicz, K., Chojnacka-Wójcik, E., Kłak, K., & Pilc, A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.002 · Cited by 33
Understanding the heterogeneity of anxiety using a translational neuroscience approach
Drzewiecki, C. M., & Fox, A. S. (2024) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-024-01162-3 · Cited by 34
A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test
Mathiasen, L., & Mirza, N. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0119-z · Cited by 32
Cues to the usefulness of grooming behavior in the evaluation of anxiety in the elevated plus-maze.
Estanislau, C. R. (2012) · Psychology & Neuroscience · doi:10.3922/j.psns.2012.1.14 · Cited by 32
Avoidant Coping Style to High Imminence Threat Is Linked to Higher Anxiety-Like Behavior
Quah, S. K. L., Cockcroft, G. J., McIver, L. B., Santangelo, A. M., & Roberts, A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00034 · Cited by 32
Effect of concomitant administration of three different antidepressants with vitamin B6 on depression and obsessive compulsive disorder in mice models
Mesripour, A., Hajhashemi, V., & Kuchak, A. (2017) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.199046 · Cited by 31
Differential effects of perinatal exposure to antidepressants on learning and memory, acoustic startle, anxiety, and open‐field activity in Sprague‐Dawley rats
Sprowles, J. L. N., Wendel, J. R. H., Gutierrez, A., Bailey, R. A., Jablonski, S. A., Williams, M. T., & Vorhees, C. V. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.06.004 · Cited by 33
The hole-board apparatus in the study of anxiety
Casarrubea, M., Giovanni, G. D., Aiello, S., & Crescimanno, G. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114346 · Cited by 30
Antidepressants differentially modify the extinction of an aversive memory task in female rats
Melo, T. G., Izídio, G. S., Ferreira, L. S., Sousa, D. S., Macêdo, P. T., Cabral, A., Ribeiro, A. M., & Silva, R. H. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.012 · Cited by 34
Social separation and diazepam withdrawal increase anxiety in the elevated plus-maze and serotonin turnover in the median raphe and hippocampus
dos Santos, L., de Andrade, T. G., & Graeff, F. G. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109106954 · Cited by 30
5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats
Salchner, P., & Singewald, N. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0247-5 · Cited by 32
Pharmacological evaluation of the stress-induced social avoidance model of anxiety
Leveleki, C., Sziray, N., Lévay, G. I., Barsvári, B., Soproni, K., Mikics, É., & Haller, J. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.11.015 · Cited by 31
Rats with constitutionally upregulated/downregulated platelet 5HT transporter: Differences in anxiety-related behavior
HRANILOVIC, D., Čičin‐Šain, L., Bordukalo-Nikšić, T., & Jernej, B. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.07.008 · Cited by 28
Evaluation of the Neurobehavioral Properties of Naringin in Swiss Mice
Ben‐Azu, B., Ekene, E. N., Umukoro, S., Aderibigbe, A. O., Ajayi, A. M., & Iwalewa, E. O. (2018) · Drug Research · doi:10.1055/a-0575-3730 · Cited by 28
Screening antidepressants in the chick separation-stress paradigm
Feltenstein, M. W., & Sufka, K. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2227-1 · Cited by 28
Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat
Muraki, I., Inoue, T., & Koyama, T. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.040 · Cited by 28
Gender difference in the prevention of hyperanxiety in adult prenatally stressed rats by chronic treatment with amitriptyline
Weinstock, M., & Poltyrev, T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1577-9 · Cited by 28
Anxiety disorders: Treatments, models, and circuitry mechanisms
Ren, L., Fan, Y., Wu, W., Qian, Y., He, M., Li, X., Wang, Y., Yang, Y., Wen, X., Zhang, R., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176994 · Cited by 35
Anxiolytic effects of a novel herbal treatment in mice models of anxiety
Doron, R., Lotan, D., Rak-Rabl, A., Raskin-Ramot, A., Lavi, K., & Rehavi, M. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.014 · Cited by 26
Bupropion effects on aggressiveness and anxiety in OF1 male mice
Redolat, R., G�mez, M. C., Vicens, P., & Carrasco, M. C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1965-9 · Cited by 27
The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse
Jacobsen, J. P. R., Plenge, P., Sachs, B. D., Pehrson, A. L., Cajina, M., Du, Y., Roberts, W. L., Rudder, M. L., Dalvi, P. H., Robinson, T. J., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3595-1 · Cited by 27
Recent findings on the pathophysiology of social anxiety disorder
Marazziti, D., Abelli, M., Baroni, S., Carpita, B., Piccinni, A., & Dell’Osso, L. (2014) · Cited by 26
Self-citation
Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism
Moy, S. S., Teng, B. L., Nikolova, V. D., Riddick, N. V., Simpson, C. D., Deusen, A. L. V., Janzen, W. P., Sassano, M. F., Pedersen, C. A., & Jarstfer, M. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.036 · Cited by 26
The chick separation stress paradigm: a validation study
Feltenstein, M. W., Warnick, J. E., Guth, A. N., & Sufka, K. J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.10.019 · Cited by 26
The effect of SSRIs on fear learning: a systematic review and meta-analysis
Heesbeen, E. J., Bijlsma, E. Y., Verdouw, P. M., Lissa, C. J. V., Hooijmans, C. R., & Groenink, L. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06333-7 · Cited by 30
Coumarin effects on amino acid levels in mice prefrontal cortex and hippocampus
Lucetti, E. C. P., Lucetti, D. L., Barbosa‐Filho, J. M., de Brito, E. M., Monteiro, V. S., Patrocínio, M. C. A., de Moura, R. R., Leal, L. K. A. M., Macêdo, D. S., de Sousa, F. C. F., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.009 · Cited by 25
Chronic repetitive transcranial magnetic stimulation is antidepressant but not anxiolytic in rat models of anxiety and depression
Hargreaves, G. A., McGregor, I. S., & Sachdev, P. S. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2005.07.008 · Cited by 25
Differential effects of NMDA receptor antagonism on spine density
Ruddy, R. M., Chen, Y., Milenkovic, M., & Ramsey, A. J. (2014) · Synapse · doi:10.1002/syn.21784 · Cited by 23
Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders
Cryan, J. F., & Dev, K. K. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00013-6 · Cited by 25
Effects of repeated asenapine in a battery of tests for anxiety-like behaviours in mice
Ene, H. M., Kara, N. Z., Barak, N., Ben-Mordechai, T. R., & Einat, H. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.53 · Cited by 24
Progressive modulation of accumbal neurotransmission and anxiety-like behavior following protracted nicotine withdrawal
Morud, J., Strandberg, J., Andrén, A., Ericson, M., Söderpalm, B., & Adermark, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.002 · Cited by 24
Bridging the species gap in translational research for neurodevelopmental disorders
Ryan, A. M., Berman, R. F., & Bauman, M. D. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.10.006 · Cited by 25
Role of serotonin type 1A receptors in fluvoxamine-induced inhibition of marble-burying behavior in mice
Harasawa, T., Ago, Y., Itoh, S., Baba, A., & Matsuda, T. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000236266.34182.1c · Cited by 23
GPR88 in D1R-Type and D2R-Type Medium Spiny Neurons Differentially Regulates Affective and Motor Behavior
Meirsman, A. C., Hamida, S. B., Clarke, E., d’Exaerde, A. D. K., Darcq, E., & Kieffer, B. L. (2019) · eNeuro · doi:10.1523/eneuro.0035-19.2019 · Cited by 24
Vinblastine and doxorubicin administration to pregnant mice affects brain development and behaviour in the offspring
Calsteren, K. V., Hartmann, D., Aerschot, L. V., Verbesselt, R., Bree, R. V., D’Hooge, R., & Amant, F. C. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.04.009 · Cited by 23
The four-plates test–retest paradigm to discriminate anxiolytic effects
Ripoll, N., Dhonnchadha, B. Á. N., Sebille, V., Bourin, M., & Hascoët, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2130-1 · Cited by 23
Animal Tests for Anxiety
Rodgers, R. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-045396-5.00002-6 · Cited by 23
Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease
Vilar-Pereira, G., Ruivo, L. A. D. S., & Lannes-Vieira, J. (2015) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150300 · Cited by 23
Elevated Anxiety and Impaired Attention in Super-Smeller, Kv1.3 Knockout Mice
Huang, Z., Hoffman, C. A., Chelette, B. M., Thiebaud, N., & Fadool, D. A. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00049 · Cited by 20
Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge
Schunck, T., Mathis, A., Erb, G., Namer, I. J., Demazières, A., & Luthringer, R. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109104864 · Cited by 22
Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats
Sant’Ana, A. B., Vilela‐Costa, H. H., Vicente, M. A., Hernandes, P. M., de Andrade, T. G. C. S., & Zangrossi, H. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.026 · Cited by 22
Restoration of peripheral V2 receptor vasopressin signaling fails to correct behavioral changes in Brattleboro rats
Balázsfi, D., Pintér, O., Klausz, B., Kovács, K., Fodor, A., Török, B., Engelmann, M., & Zelena, D. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.011 · Cited by 21
Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands
Bell, R., Duke, A. A., Gilmore, P. E., Page, D., & Bègue, L. (2014) · Scientific Reports · doi:10.1038/srep03881 · Cited by 21
Psychotropic and Neurotropic Activity
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_6 · Cited by 22
ATC0175: An Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonist for the Potential Treatment of Depression and Anxiety
Chaki, S., Yamaguchi, J.-I., Yamada, H., Thomsen, W. J., Tran, T.-A., Semple, G., & Sekiguchi, Y. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00052.x · Cited by 20
Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties
Artaiz, I., Zazpe, A., Innerárity, A., del Olmo, E., Díaz, Á., Ruíz-Ortega, J. Á., Castro, E., Pena, R., Labeaga, L., Pazos, Á., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0087-3 · Cited by 20

Authors: Borsini, F., Podhorna, J., & Marazziti, D.
Affiliations: Boehringer Ingelheim (Germany) (DE)
University of Pisa (IT)
ORCID: Marazziti, Donatella
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2002-09-01
Volume: 163
Issue: 2
Pages: 121-141
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-002-1155-6
OpenAlex: W2069192879
Cited by: 347
References: 1
Citations by year: 2026: 1 · 2025: 2 · 2024: 8 · 2023: 12 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 14 · 2017: 12 · 2016: 14 · 2015: 17 · 2014: 21 · 2013: 9 · 2012: 12
FWCI: 6.04
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: animal models of anxiety, antidepressants, anxiolytic-like effects, selective serotonin reuptake inhibitors, benzodiazepines, predictive validity, marble burying test, conditioned freezing, ultrasonic vocalizations, plus-maze test, light-dark transition test, stress-induced hyperthermia, anxiety disorders
MeSH terms: Animals, Antidepressive Agents, Tricyclic, Anxiety, Disease Models, Animal, Forecasting, Humans, Anti-Anxiety Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Do animal models of anxiety predict anxiolytic-like effects of antidepressants?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks